Introduction

Injectable treatments are increasingly used for facial rejuvenation, collagen stimulation and volume restoration. At Millennium Clinic Kuala Lumpur, a doctor-led consultation and comprehensive facial assessment can help determine whether Lenisna, a traditional dermal filler or another treatment is appropriate for a patient’s anatomy, skin condition and goals.

Although Lenisna and traditional dermal fillers are both administered by injection, they work through different biological mechanisms. Lenisna combines poly-D,L-lactic acid, or PDLLA, with non-cross-linked hyaluronic acid and is primarily used to support gradual collagen remodelling. Traditional cross-linked hyaluronic acid fillers provide immediate physical volume and structural support.

Neither option is universally better. Treatment selection should be based on clinical assessment rather than product popularity. The doctor must consider facial proportions, volume distribution, skin quality, tissue laxity, medical history, previous injectables and whether the patient wants gradual or immediate change.

 

Image credit: Gustavo Fring via Pexels.

Key Takeaways

How is Lenisna different from traditional dermal fillers?

Lenisna and traditional dermal fillers are designed for different treatment goals. Lenisna gradually stimulates the body’s collagen-related tissue response to support skin quality over time, whereas traditional cross-linked hyaluronic acid fillers primarily restore facial volume immediately. The most appropriate treatment depends on facial anatomy, skin condition, ageing concerns and medical assessment.

• Understand the treatment mechanism: Lenisna combines poly-D,L-lactic acid microparticles with non-cross-linked hyaluronic acid to support progressive collagen remodelling. Traditional HA fillers use a cross-linked gel to provide immediate physical volume.
• Match treatment to the concern: Lenisna may be considered for collagen stimulation, mild laxity, selected acne scars and broader skin-quality concerns. Dermal fillers are generally used for volume loss, facial contouring, deep folds and structural enhancement.
• Expect different timelines: The non-cross-linked HA and treatment fluid in Lenisna may cause early fullness, but collagen-related changes develop gradually. A clinical study of a PDLLA-and-HA injectable followed patients through 24 weeks, illustrating why meaningful biostimulatory results are assessed over several months.
• Plan for approximately 3–6 months: Lenisna-related collagen remodelling is commonly evaluated progressively over approximately three to six months. This is an assessment window, not a promise that every patient will respond within an identical period.
• Understand filler speed: The American Academy of Dermatology states that hyaluronic acid gel fillers generally produce immediate results, although swelling can temporarily affect the initial appearance.
• Expect an individual treatment course: Some Lenisna patients may undergo approximately two or three sessions, but the appropriate number and interval vary. Traditional filler may provide the planned correction in one appointment, followed by later maintenance.
• Follow personalised treatment planning: A comprehensive assessment should determine whether Lenisna, traditional filler, a combination plan or no injectable treatment is most appropriate.
• Prioritise long-term safety: Qualified medical treatment, authentic products, conservative dosing, proper aftercare and scheduled follow-up contribute to safer and more natural-looking facial rejuvenation.

What Is Lenisna?

A hybrid collagen biostimulator

Lenisna is an injectable formulation containing PDLLA microparticles and non-cross-linked hyaluronic acid. These ingredients have different functions.

The HA component attracts water, supports product distribution and may provide temporary hydration or initial fullness. The PDLLA component is intended to initiate a controlled local response that supports collagen formation and extracellular-matrix remodelling.

Lenisna is therefore commonly described as a collagen biostimulator rather than simply a conventional volume filler.

What is Poly-D,L-Lactic Acid?

PDLLA is a biodegradable synthetic polymer composed of D- and L-lactic-acid forms. It has an amorphous structure that differs from poly-L-lactic acid, or PLLA.

After PDLLA is placed into an appropriate tissue plane, the body begins processing the particles. Cells involved in material clearance and tissue repair gather around them. These cells include macrophages and fibroblasts.

Chemical signals generated during this process may encourage fibroblasts to produce new extracellular-matrix material, particularly collagen. The response should remain controlled. Poor product distribution, unsuitable injection depth or excessive concentration may increase the risk of lumps or inflammatory nodules.

What is non-cross-linked hyaluronic acid?

Hyaluronic acid is naturally present in the extracellular matrix and can bind water. The behaviour of injectable HA depends heavily on whether and how it is cross-linked.

Non-cross-linked HA is usually softer and metabolised more quickly than a structural filler gel. In Lenisna, it helps suspend the PDLLA particles and may provide short-term hydration.

Any immediate fullness should not be interpreted as newly produced collagen. It may result from:

• Injected fluid;
• Non-cross-linked HA;
• Water attraction;
• Temporary inflammation; and
• Post-injection swelling.

How collagen biostimulation works

Collagen biostimulation uses a material or controlled procedure to encourage the patient’s own tissue-remodelling response.

Following Lenisna injection:

1. PDLLA particles are deposited in a selected tissue plane.
2. A mild local inflammatory response begins.
3. Macrophages interact with and process the particles.
4. Fibroblasts receive repair-related signals.
5. Collagen is gradually deposited around the treated tissue.
6. Collagen fibres reorganise as the PDLLA material degrades.

A peer-reviewed consensus on injectable PDLLA reports that type I collagen may be observed around PDLLA microspheres during tissue remodelling. Much of the detailed histological evidence comes from laboratory or animal studies, so it cannot guarantee an identical clinical response in every patient.

Type I and Type III collagen

Type I collagen provides substantial structural strength in mature skin. Type III collagen is associated with early repair and forms part of the dermal collagen network.

Biostimulation involves a dynamic remodelling process rather than the production of one collagen type in isolation. Early tissue repair may involve type III collagen, while type I collagen becomes important in longer-term structural organisation.

It is more accurate to say that PDLLA supports collagen-related remodelling than to promise a specific amount of new type I or type III collagen in an individual patient.

Why results develop gradually

Fibroblast activation, collagen production and fibre maturation take time. Patients may begin noticing changes after several weeks, with further development over subsequent months.

Age, baseline collagen, smoking, sun exposure, general health, treatment technique and product distribution can influence the response.

What Are Traditional Dermal Fillers?

Hyaluronic acid fillers

Traditional facial fillers commonly contain cross-linked HA gel. Cross-linking connects HA molecules to create a material that resists rapid breakdown and provides physical support.

The US Food and Drug Administration explains that hyaluronic acid gel combines with water and creates a smoothing or filling effect. Approved products, treatment areas and indications vary between countries.

Cross-linked HA technology

Manufacturers use different cross-linking methods to produce gels with distinct physical characteristics. These characteristics include:

• Firmness;
• Elasticity;
• Cohesivity;
• Flexibility;
• Water attraction;
• Resistance to compression; and
• Ability to maintain projection.

A firm structural filler may be used for the chin or cheek, while a softer and more flexible product may be selected for mobile areas. No single filler is appropriate for every facial region.

Immediate volume replacement

Traditional filler occupies space immediately after injection. This makes it useful for:

• Replacing lost volume;
• Supporting a facial fold;
• Filling a selected depression;
• Improving projection;
• Correcting mild asymmetry; and
• Enhancing facial contours.

Swelling may make the early result appear fuller than the final result. Patients should wait until swelling settles before deciding whether more product is required.

Facial contour enhancement

Cross-linked HA filler may be considered for contouring areas such as the:

• Cheeks;
• Chin;
• Jawline;
• Temples;
• Lips;
• Nasolabial folds;
• Marionette region; and
• Under-eye area.

Not every patient is suitable for filler in all these locations. Under-eye and temple injections, for example, require particularly careful assessment because of complex anatomy and the potential for visible irregularities or vascular complications.

Structural support

A suitable filler can be placed at deeper anatomical levels to provide support or projection. However, adding filler does not physically tighten all loose skin.

Excessive filler used in an attempt to “lift” substantial laxity may create heaviness, distorted proportions or an overfilled appearance. Patients with advanced tissue descent may need to consider HIFU, other energy-based treatments or surgical assessment.

How Do Their Treatment Mechanisms Differ?

Lenisna: biological tissue remodelling

Lenisna’s main intended mechanism is a gradual biological response. PDLLA particles act as a temporary stimulus while the patient’s tissue produces and reorganises collagen.

Potential changes may include:

• Increased collagen deposition;
• Progressive extracellular-matrix remodelling;
• Better dermal support;
• Improved firmness;
• Smoother-looking texture; and
• Gradual reduction in selected depressions.

This response is less immediately predictable than placing a measured amount of HA gel. The body determines part of the final outcome.

Traditional fillers: mechanical volume replacement

Traditional filler works primarily through the physical presence of HA gel. The injector selects a product and places a measured amount in a particular anatomical location.

The result depends on:

• Product rheology;
• Injection depth;
• Volume used;
• Facial movement;
• Existing tissue support; and
• The patient’s anatomy.

Although HA fillers may interact with surrounding tissue, immediate physical correction remains their principal role.

Why the mechanisms are fundamentally different

Lenisna stimulates a gradual biological process. Traditional filler creates an immediate mechanical effect.

This distinction affects:

• Treatment planning;
• Speed of results;
• Precision of contouring;
• Number of sessions;
• Maintenance;
• Reversibility; and
• Management of complications.

Which Facial Concerns Does Each Treatment Address?

Volume loss

Traditional HA filler is usually more appropriate when a patient needs immediate and precisely placed volume. It can restore cheek projection, support a fold or enhance the chin.

Lenisna may be considered for mild or diffuse volume loss when the goal is progressive tissue support. It is less suitable for patients expecting an exact immediate shape.

Skin laxity

Lenisna may improve the appearance of mild laxity through gradual collagen remodelling. It cannot replicate a surgical facelift and may be inadequate for significant sagging.

Filler can support carefully selected areas, but it does not directly tighten the entire skin envelope. HIFU or Sylfirm X may be considered when tightening is a separate treatment objective.

Acne scars

Lenisna may be included in an acne scar treatment plan for selected broad or depressed scars. Collagen stimulation may gradually improve surrounding tissue quality.

Traditional HA filler can provide immediate elevation of certain individual depressions. However, filler placed beneath a scar that remains strongly tethered may produce limited improvement.

Rolling scars may require subcision. Deep ice pick scars may require focal treatment, while fractional CO₂ laser or RF microneedling may be used for broader texture.

A small study involving five Asian participants reported improvement in atrophic scars after PDLLA was delivered through a specialised microjet system. Because of its size and specific technique, this early acne-scar evidence should be interpreted cautiously.

Enlarged pores

Lenisna may indirectly improve pore appearance when collagen remodelling improves the surrounding skin. It cannot permanently close pores.

Traditional structural fillers are not generally used to treat enlarged pores. More directly relevant options may include Sylfirm X, microneedling, fractional laser, pico fractional treatment or appropriate skincare.

Fine lines

Fine lines may result from dehydration, sun damage, muscle movement or collagen loss.

Lenisna may support broader collagen remodelling, but it is not necessarily the best treatment for isolated superficial lines. Skin Boosters, Rejuran, resurfacing treatments or carefully selected soft fillers may be considered.

Wrinkles

Treatment should be based on the cause:

• Muscle-related wrinkles may respond to a neuromodulator;
• Volume-related folds may benefit from dermal filler;
• Fine surface lines may need resurfacing;
• General collagen loss may support consideration of Lenisna.

Neither product should be viewed as a universal wrinkle treatment.

Skin texture

Lenisna may support gradual improvement in firmness and broad textural irregularity. Traditional filler is more suitable for a specific depression than for diffuse roughness.

Skin-quality treatments such as Skin Boosters, Juvelook, Rejuran, PRP or fractional devices may have complementary roles.

Facial contour

Traditional filler is generally better suited to immediate contour enhancement. Its physical gel properties allow more precise chin, cheek or jawline projection.

Lenisna may provide gradual support but is not intended to create an instantly sculpted contour. Patients seeking facial fillers Kuala Lumpur services should be assessed for facial proportions instead of choosing treatment according to a standard number of syringes.

Skin hydration

The non-cross-linked HA in Lenisna may provide temporary hydration. However, Lenisna’s main longer-term purpose is collagen biostimulation.

A dedicated skin booster may be more suitable when dryness and superficial hydration are the primary concerns. Traditional structural filler should not be used simply as a skin moisturiser.

 

Image credit: Hanna Pad via Pexels.

Comprehensive Comparison Table

Treatment Decision Guide

Can Lenisna and Dermal Fillers Be Combined?

Yes. Lenisna and traditional HA filler may be included in one treatment plan when they address separate concerns.

Facial balancing

Traditional filler may be used to provide precise chin or cheek projection, while Lenisna is used more broadly for gradual collagen support.

Facial balancing should aim for proportion and harmony, not maximum volume.

Combination rejuvenation

A comprehensive plan may involve:

• HA filler for immediate structure;
• Lenisna for gradual collagen stimulation;
• Skin Boosters for hydration;
• HIFU for selected laxity;
• Sylfirm X for texture or pores;
• PRP as an adjunct;
• Fractional laser for scars; or
• Pico laser for selected pigmentation.

Every additional procedure should have a distinct clinical purpose.

Treatment sequencing

A possible plan might include:

1. Medical consultation and photography;
2. Structural HA filler in selected areas;
3. Review after swelling settles;
4. Lenisna treatment in a separate tissue plane or area;
5. Collagen-response assessment over three to six months; and
6. Addition of a surface treatment only if still needed.

Another patient may receive Lenisna before filler. There is no universal sequence.

Layered treatment planning

The face contains several tissue layers. A doctor may use a structural filler near deeper support points and a biostimulator in a broader subcutaneous plane.

Layered treatment should not mean placing multiple products unnecessarily in the same location. Previous injectable products, including permanent fillers, must be disclosed.

Safety considerations

Combining injectables may increase:

• Swelling;
• Bruising;
• Product overlap;
• Inflammation;
• Lumps;
• Difficulty identifying the cause of a reaction; and
• Total treatment cost.

Staging treatments can make the response easier to assess.

Who May Be More Suitable for Lenisna?

Lenisna may be considered for adults with:

• Early signs of facial ageing;
• Mild skin laxity;
• Gradual reduction in firmness;
• Diffuse early volume loss;
• Selected acne scars;
• Enlarged-looking pores;
• Uneven texture;
• A preference for progressive improvement; and
• Realistic expectations about multiple sessions.

Suitability depends on clinical need, not age alone. A younger person with acne scars may have an appropriate indication, while another patient of the same age may not need injectable treatment.

Who May Be More Suitable for Traditional Dermal Fillers?

Traditional fillers may be considered for adults with:

• Clear facial volume loss;
• Deep nasolabial folds associated with structural changes;
• Chin retrusion or limited projection;
• Jawline contour concerns;
• Selected temple or cheek hollowing;
• Lip-volume concerns;
• A specific facial depression; or
• A preference for immediate correction.

Immediate correction does not mean the final result is visible on treatment day. Swelling and bruising still require time to settle.

Benefits

Benefits of Lenisna

Potential benefits include:

• Gradual and potentially natural-looking progression;
• Broader collagen-related tissue support;
• Possible improvement in mild firmness;
• Potential improvement in selected skin textures;
• A possible role in depressed acne scars;
• Less reliance on immediate physical overfilling; and
• Compatibility with selected facial rejuvenation treatments.

Results cannot be guaranteed, and some patients may experience only modest improvement.

Benefits of Traditional Dermal Fillers

Potential benefits include:

• Immediate physical volume;
• Precise contour enhancement;
• A range of gel consistencies;
• Measurable correction during treatment;
• Suitability for lips, cheeks, chin and other selected areas;
• Ability to treat an isolated depression; and
• Potential reversibility of many HA products.

Filler must still be used conservatively. More volume does not necessarily produce a more youthful or attractive result.

 

Image credit: Dr. Haror’s Wellness via Pexels. Image used for general illustration; the exact injectable product may differ.

Limitations

Gradual versus immediate improvement

Lenisna may frustrate patients expecting immediate contouring. Traditional filler may be unsuitable for patients who want gradual collagen support without a clearly visible volume change.

Number of sessions

Lenisna may require two or three sessions, but some patients need fewer or more. HA filler may achieve the intended correction during one appointment, although maintenance may be required later.

Maintenance

Neither treatment stops ageing. Maintenance should be based on reassessment, not an automatic schedule.

Cost considerations

A Lenisna series may have a higher initial total cost than a single filler session. Repeated dermal filler appointments may also accumulate significant costs over time.

Patients should understand:

• Product cost;
• Number of sessions;
• Follow-up fees;
• Maintenance expectations;
• Alternative treatments; and
• Which treatments are essential rather than optional.

Individual suitability

Some patients may be better served by skincare, HIFU, laser, surgery or no treatment. Injectables cannot correct every concern.

Patient expectations

No injectable can guarantee perfect symmetry, poreless skin, permanent lifting or complete scar removal. The goal should be medically reasonable improvement.

Safety Considerations

Medical assessment

Before treatment, the doctor should review:

• Medical conditions;
• Allergies;
• Autoimmune or inflammatory disease;
• Current medicines and supplements;
• Bleeding or bruising tendency;
• Pregnancy or breastfeeding;
• Active infection;
• Previous fillers and biostimulators; and
• Previous treatment complications.

Qualified injector

Both Lenisna and HA filler are medical procedures. The injector should understand facial anatomy, product behaviour and complication management.

The FDA recommends choosing a licensed healthcare provider with experience in fillers, facial anatomy and emergency management.

Contraindications

Treatment may need to be postponed or avoided in patients with:

• Active infection in or near the treatment area;
• Known allergy to a product component;
• Uncontrolled inflammatory or autoimmune disease;
• Significant bleeding disorders;
• Poor wound healing;
• Certain previous permanent fillers; or
• Unrealistic expectations.

Pregnancy and breastfeeding

Elective injectable treatments are generally postponed during pregnancy because adequate safety evidence is lacking. Breastfeeding suitability also requires medical discussion.

Autoimmune disease

An autoimmune diagnosis does not create one universal rule. Disease activity, medication use and immune status need individual evaluation.

Potential side effects

Common temporary effects include:

• Redness;
• Swelling;
• Tenderness;
• Bruising;
• Itching;
• Mild asymmetry; and
• Palpable product.

Less common complications include:

• Infection;
• Persistent nodules;
• Granulomatous inflammation;
• Delayed swelling;
• Product migration;
• Skin irregularity;
• Allergic reactions;
• Vascular occlusion;
• Tissue necrosis; and
• Visual impairment.

The most serious filler risk is accidental injection into a blood vessel. This may result in tissue injury, blindness or stroke.

HA filler can often be treated with hyaluronidase. The PDLLA component of Lenisna cannot simply be dissolved, making accurate placement particularly important.

Recovery and Aftercare

Swelling and bruising

Mild swelling, bruising and tenderness can occur after either treatment. Lenisna-related swelling may temporarily exaggerate fullness before settling.

Apply a clean, wrapped cool pack only if recommended. Do not place ice directly on the skin.

Exercise restrictions

Strenuous exercise may worsen swelling or bruising. Patients should follow the clinic’s instructions about when to restart exercise.

Sun protection

Use broad-spectrum sunscreen and reduce direct sun exposure. Sun protection helps limit avoidable collagen damage and reduces pigmentation risk following bruising or inflammation.

Massage

Some PDLLA protocols include massage, but patients should massage only if the treating doctor specifically recommends it.

Do not massage HA filler unless instructed. Unnecessary pressure may affect swelling or product placement.

Follow-up visits

Follow-up allows the doctor to assess:

• Swelling;
• Symmetry;
• Palpable areas;
• Delayed nodules;
• Filler position;
• Collagen-related change; and
• Whether further treatment is justified.

Aftercare Checklist

Contact the clinic promptly for spreading redness, pus, fever, unusual discolouration, severe pain, persistent lumps or changes in vision.

 

Image credit: SHVETS production via Pexels.

Frequently Asked Questions

1. Is Lenisna a dermal filler?

Lenisna has both temporary filling and biostimulatory characteristics. Its principal longer-term purpose is PDLLA-related collagen stimulation rather than immediate structural filling alone.

2. Is Lenisna better than traditional dermal filler?

No. Lenisna may suit gradual collagen support, while HA filler may suit immediate volume restoration. The appropriate option depends on the patient.

3. When will I see Lenisna results?

Temporary fullness may be visible immediately, but collagen-related improvement generally develops over approximately three to six months.

4. When will I see HA filler results?

HA filler creates an immediate volume change. The result should be reassessed after initial swelling has settled.

5. How many Lenisna sessions are needed?

Some patients may undergo approximately two or three sessions. The correct number and interval depend on anatomy, response and treatment goals.

6. Can Lenisna improve acne scars?

It may support selected depressed scars, but it cannot release every tethered rolling scar or close deep ice pick scars. Combination treatment may be necessary.

7. Which treatment is better for chin enhancement?

Traditional structural HA filler is generally more suitable for immediate, precise chin projection. Lenisna may provide gradual support but less exact immediate contouring.

8. Can Lenisna and HA filler be combined?

Yes, when they address separate concerns. A doctor should plan the location, depth, amount and sequence carefully.

9. Can Lenisna be dissolved?

The non-cross-linked HA may respond to hyaluronidase, but PDLLA particles cannot simply be dissolved.

10. Can traditional HA filler be dissolved?

Many HA fillers can be broken down with hyaluronidase. Dissolving filler is still a medical procedure and may require more than one session.

11. Which treatment lasts longer?

Duration varies substantially. Lenisna depends on the collagen response, while filler duration depends on product characteristics, location and metabolism.

12. How should I choose an injectable clinic in Kuala Lumpur?

Choose a doctor-led clinic that assesses facial anatomy, explains product differences, uses authentic products and provides a clear complication-management and follow-up plan.

Conclusion

The principal difference in Lenisna vs traditional dermal fillers is their treatment mechanism. Lenisna combines PDLLA particles with non-cross-linked HA and is primarily intended to support gradual collagen remodelling. Traditional cross-linked HA filler produces immediate physical volume and is usually better suited to precise facial contouring.

Lenisna may be considered for mild laxity, broad skin-quality concerns, gradual tissue support and selected acne scars. HA filler may be more appropriate for immediate cheek, chin, jawline, lip or fold correction.

Some patients may benefit from a combination plan, while others need only one treatment or no injectable procedure. Treatment should always be based on facial anatomy, skin quality, previous products, medical history and realistic goals.

Millennium Clinic Kuala Lumpur is a doctor-led aesthetic clinic offering evidence-based facial assessment and personalised treatment planning. Following an examination, the doctor can explain whether Lenisna, traditional HA filler, Skin Boosters, Juvelook, Sylfirm X, HIFU, PRP or another skin rejuvenation treatment is most appropriate.

References

1. American Academy of Dermatology Association. “Fillers: FAQs.”
   https://www.aad.org/public/cosmetic/wrinkles/fillers-faqs
2. US Food and Drug Administration. “FDA-Approved Dermal Fillers.”
   https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers
3. US Food and Drug Administration. “Dermal Filler Do’s and Don’ts for Wrinkles, Lips and More.”
   https://www.fda.gov/consumers/consumer-updates/dermal-filler-dos-and-donts-wrinkles-lips-and-more
4. National Library of Medicine, PubMed Central. “A Split Face Study Comparing the Effect of a PDLLA-Based Product and PLLA on the Nasolabial Fold.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC12802405/
5. National Library of Medicine, PubMed Central. “Consensus Recommendations for the Reconstitution and Aesthetic Use of Poly-D,L-Lactic Acid Microspheres.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC11626391/
6. National Library of Medicine, PubMed Central. “Poly-D,L-Lactic Acid-Enhanced Atrophic Scar Treatment via Transdermal Microjet Drug Delivery in Asians.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC11187807/